What are the next steps for a patient with an O-RADS (Ovarian-Adnexal Reporting and Data System) 2 score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of O-RADS 2 Lesions

For patients with an O-RADS 2 score (almost certainly benign lesions with <1% risk of malignancy), follow-up ultrasound or no follow-up is recommended depending on specific characteristics of the lesion and patient menopausal status.

Definition and Risk Assessment

  • O-RADS 2 represents the "almost certainly benign" category with less than 1% risk of malignancy 1
  • This category comprises the majority of unilocular cysts less than 10 cm, including simple cysts, nonsimple unilocular cysts with smooth walls, and classic benign lesions 1
  • Recent research confirms the extremely low malignancy rate in O-RADS 2 lesions, with one study showing less than 1% (1 of 157) of surgically resected O-RADS 2 lesions were malignant 2
  • External validation studies have demonstrated 0% malignancy rate (0 of 100) for lesions classified as O-RADS 2 3

Management Based on Lesion Type and Size

Simple Cysts

  • Premenopausal women:

    • Simple cysts ≤3 cm: No follow-up needed 1, 4
    • Simple cysts >3 cm to ≤5 cm: No additional management required 4
    • Simple cysts >5 cm but <10 cm: Follow-up ultrasound in 8-12 weeks 1, 5
  • Postmenopausal women:

    • Simple cysts ≤3 cm: No follow-up needed 4
    • Simple cysts >3 cm but <10 cm: Follow-up in 1 year, with consideration of annual follow-up for up to 5 years if stable 1, 5

Classic Benign Lesions <10 cm

  • Typical hemorrhagic cyst:

    • <5 cm: Referral to US specialist, gynecologist, or MRI 1
    • 5 cm but <10 cm: Follow-up in 8-12 weeks; if persists or enlarges, referral to US specialist, gynecologist, or MRI 1

  • Typical dermoid cyst <10 cm:

    • Referral to US specialist, gynecologist, or MRI 1
    • With confident diagnosis, if not removed surgically, annual US follow-up should be considered 1
  • Typical endometrioma <10 cm:

    • US specialist or MRI if there is enlargement, changing morphology, or a developing vascular component 1
  • Simple paraovarian cyst:

    • No follow-up needed; optional single follow-up study in a year 1
  • Typical peritoneal inclusion cyst:

    • Referral to gynecologist 1
  • Typical hydrosalpinx (any size):

    • Referral to gynecologist 1

Non-simple Unilocular Cyst with Smooth Inner Margin

  • Premenopausal women:

    • <3 cm: No follow-up needed 1
    • 3 cm but <10 cm: Follow-up in 8-12 weeks; if concerning, US specialist 1

  • Postmenopausal women:

    • 3 cm but <10 cm: US specialist 1

Important Considerations

  • Transvaginal ultrasound is preferred for evaluation but may be augmented by transabdominal or transrectal approaches as needed 1
  • The size of the lesion should be measured by the largest diameter regardless of the plane 1
  • In cases of multiple lesions, each should be separately characterized, with management driven by the lesion with the highest O-RADS score 1
  • The O-RADS US system is based on an average-risk patient with no acute symptoms and no substantial risk factors for ovarian cancer 1

Common Pitfalls to Avoid

  • Unnecessary surgical intervention for O-RADS 2 lesions - a recent study showed that 42% of surgically resected lesions met O-RADS 2 criteria and could have been managed conservatively 2
  • Failing to perform adequate follow-up for cysts >5 cm, as larger cysts may be more challenging to evaluate completely 5
  • Not distinguishing between simple cysts and other cyst types which have different management protocols 4
  • Overlooking the possibility of functional cysts in premenopausal women, which typically resolve within 8-12 weeks 5

When to Consider MRI

  • When ultrasound evaluation is incomplete (O-RADS 0) due to technical factors 1
  • For further characterization of lesions with uncertain features 1
  • MRI using the O-RADS MRI scoring system has shown high diagnostic performance for characterization of US-indeterminate adnexal lesions 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Follow-up Management for Left Ovarian Simple Cyst

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Adnexal Cysts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.